Click here for slides on this topic

Intermediate-acting insulin

A type of insulin that starts to lower blood glucose within 1 to 2 hours after injection and has its strongest effect 6 to 12 hours after injection, depending on the type used.
The following content matched the glossary term: Intermediate-acting insulin Expert Commentary on Type 2 Diabetes Treatment Trends from Vivian Fonseca, MD


NDEI Education Council Member Vivian A. Fonseca, MD, comments on a study exploring type 2 diabetes treatment trends in the U.S.: “Clinicians could use these data to determine whether their own prescribing has changed in line with national trends”

Ambulatory treatment of type 2 diabetes in the U.S., 1997-2012


Exclusive! Expert commentary from Vivian A. Fonseca, MD, on this study. Turner LW, Nartey D, Stafford RS, Singh S, Alexander GC. Ambulatory treatment of type 2 diabetes in the U.S., 1997-2012. Diabetes Care. 2014;37:985-992.

ADA 2016 Type 1 Diabetes Pharmacologic Therapy


Type 1 diabetes treatment options from the 2016 ADA guidelines

ADA 2016 Insulin & Glucose Monitoring


Recommendations for insulin and glucose monitoring in diabetes (SMBG) from the 2016 ADA guidelines

ADA 2016 Type 2 Diabetes Pharmacologic Therapy


Pharmacologic treatment options for type 2 diabetes from the 2016 ADA guidelines

Comparison of glycemic variability assocd with insulin glargine, intermed-acting insulin when basal component of multiple injections for adolescents with T1D


White NH, Chase HP, Arslanian S, Tamborlane WV for the 4030 Study Group. Comparison of glycemic variability associated with insulin glargine and intermediate-acting insulin when used as the basal component of multiple daily injections for adolescents with type 1 diabetes. Diabetes Care. 2009;32(3):387-393. OBJECTIVE: To compare the glucose variability associated with insulin glargine and NPH/Lente insulin used as the basal insulin component of a multiple daily injection (MDI) regimen in pediatric patients with type 1 diabetes.

Product Indications


Medications used to treat diabetes :: Alpha-glucosidase inhibitors, amylin mimetics, biguanides (metformin), bile acid sequestrants, dopamine receptor agonists, DPP-4 inhibitors, GLP-1 analogs, incretins, insulin, meglitinides, SGLT2 inhibitors, sulphonylureas, thiazolidinediones (TZDs).

Slide Library Results

Search Results for: Intermediate-acting insulin Slides Found: 0